ChemicalBook >> CAS DataBase List >>PF-06282999

PF-06282999

CAS No.
1435467-37-0
Chemical Name:
PF-06282999
Synonyms
CS-2543;PF-06282999;PF-06282999 (Free base);PF-06282999 (PF06282999;PF-06282999 >=98% (HPLC);PF-06282999, 10 mM in DMSO;PF-06282999;PF 06282999;PF06282999;PF06282999,Glutathione Peroxidase,PF 06282999,PF-06282999,Inhibitor,inhibit;1(2H)-Pyrimidineacetamide, 6-(5-chloro-2-methoxyphenyl)-3,4-dihydro-4-oxo-2-thioxo-;2-(6-(5-chloro-2-methoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamide
CBNumber:
CB93145903
Molecular Formula:
C13H12ClN3O3S
Molecular Weight:
325.77
MDL Number:
MFCD30533689
MOL File:
1435467-37-0.mol
Last updated:2025-10-29 15:43:00
Product description Number Pack Size Price
PF-06282999 ≥98% (HPLC) PZ0375 5mg $89.3
PF-06282999 28406 1mg $44
PF-06282999 28406 5mg $97
PF-06282999 28406 10mg $172
PF-06282999 28406 25mg $374
More product size

PF-06282999 Properties

Density 1.52±0.1 g/cm3(Predicted)
storage temp. room temp
solubility DMSO:30.0(Max Conc. mg/mL);92.1(Max Conc. mM)
form powder
pka 6.85±0.40(Predicted)
color white to beige
FDA UNII YO3O4Q2NC8
UNSPSC Code 51111800
NACRES NA.77

SAFETY

Risk and Safety Statements

Symbol(GHS)  GHS hazard pictograms
GHS07
Signal word  Warning
Hazard statements  H302-H315-H319-H335
Precautionary statements  P261-P305+P351+P338

PF-06282999 price More Price(8)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich PZ0375 PF-06282999 ≥98% (HPLC) 1435467-37-0 5mg $89.3 2025-07-31 Buy
Cayman Chemical 28406 PF-06282999 1435467-37-0 1mg $44 2024-03-01 Buy
Cayman Chemical 28406 PF-06282999 1435467-37-0 5mg $97 2024-03-01 Buy
Cayman Chemical 28406 PF-06282999 1435467-37-0 10mg $172 2024-03-01 Buy
Cayman Chemical 28406 PF-06282999 1435467-37-0 25mg $374 2024-03-01 Buy
Product number Packaging Price Buy
PZ0375 5mg $89.3 Buy
28406 1mg $44 Buy
28406 5mg $97 Buy
28406 10mg $172 Buy
28406 25mg $374 Buy

PF-06282999 Chemical Properties,Uses,Production

Uses

PF-06282999 is a potent and selective myeloperoxidase inhibitor which is potential useful for the treatment of cardiovascular diseases.

Biological Activity

PF-06282999 is an orally active thiouracil class myeloperoxidase (MPO) suicide substrate (kinact/KI = 11600 M-1s-1) th at targets MPO heme group for mechanism-based irreversible inactivation wtih high selectivity over thyroid peroxidase (TPO kinact/KI <3 M-1s-1) and heme-containing cytochrome P450 (CYP) isoforms (IC50 >100 μM). PF-06282999 effectively inhibits MPO activity in human blood stimulated by LPS ex vivo (IC50 = 1.9 μM) and in blood of LPS-treated cynomolgus monkeys in vivo (5-80 mg/kg p.o. 1hr post LPS i.v.) with good pharmacokinetics and oral availability (100%/86%/75%/76% in mice/rats/dogs/monkeys). PF-06282999 also exhibits weak PXR activating activity (EC50/Emax = 279 μM/9.36-fold vs.0.8 μM/19.6-fold with rifampin).

in vivo

PF-06282999 is moderately bound to plasma proteins across preclinical species and humans. The blood/plasma ratios for PF-06282999 are 1.1, 1.1, 0.91, 1.2, and 0.94 in mice, rats, dogs, monkeys, and humans, respectively, suggesting that PF-06282999 is equally distributed into plasma and red blood cells[1]. The in vivo pharmacokinetics of PF-06282999 are examined in greater detail in mice, rats, dogs, and monkeys, wherein it is demonstrated to have low CLp in mice (10.1 mL/min/kg), dogs (3.39 mL/min/kg), monkeys (10.3 mL/min/kg) and moderate CLp in rats (41.8 mL/min/kg). The terminal plasma elimination half-lives (t1/2) range from 0.75 to 3.3 h in the four species. Approximately 26-32% of the iv dose of PF-06282999 is excreted in the unchanged form in rat, dog, and monkey urine, wherein it is also shown that it is well distributed with steady state distribution volumes (Vdss) ranging from 0.5-2.1 L/kg in mice, rats, dogs, and monkeys. Following oral administration, PF-06282999 is rapidly (Tmax=0.78-1.70 h) and well absorbed in mice, rats, dogs, and monkeys with oral bioavailability values of 100%, 86%, 75%, and 76%, respectively[2].

References

[1] Dong JQ, et al. Pharmacokinetics and Disposition of the Thiouracil Derivative PF-06282999, an Orally Bioavailable, Irreversible Inactivator of Myeloperoxidase Enzyme, Across Animals and Humans. Drug Metab Dispos. 2016 Feb;44(2):209-19. DOI:10.1124/dmd.115.067868
[2] Ruggeri RB, et al. Discovery of 2-(6-(5-Chloro-2-methoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamide (PF-06282999): A Highly Selective Mechanism-Based Myeloperoxidase Inhibitor for the Treatment of Cardiovascular Diseases. J Med Chem. 20 DOI:10.1021/acs.jmedchem.5b00963

3438-16-2
1435467-37-0
Synthesis of PF-06282999 from 5-Chloro-2-methoxybenzoic acid
Global( 60)Suppliers
Supplier Tel Email Country ProdList Advantage
ATK CHEMICAL COMPANY LIMITED
+undefined-21-51877795 ivan@atkchemical.com China 33024 60
BOC Sciences
+1-631-485-4226 inquiry@bocsci.com United States 19552 58
career henan chemical co
+86-0371-86658258 +8613203830695 factory@coreychem.com China 29799 58
HANGZHOU CLAP TECHNOLOGY CO.,LTD
86-571-88216897,88216896 13588875226 sales@hzclap.com CHINA 6312 58
InvivoChem
+1-708-310-1919 +1-13798911105 sales@invivochem.cn United States 6391 58
TargetMol Chemicals Inc.
+1-781-999-5354; support@targetmol.com United States 39035 58
Aladdin Scientific
tp@aladdinsci.com United States 57505 58
Amadis Chemical Company Limited
571-89925085 sales@amadischem.com China 131957 58
Adamas Reagent, Ltd. 400-6009262 16621234537 chenyj@titansci.com China 14101 59
Shanghai Lollane Biological Technology Co.,Ltd. 021-52996696,15000506266 15000506266 China 4764 55

View Lastest Price from PF-06282999 manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
	PF-06282999 pictures 2019-12-24 PF-06282999
1435467-37-0
US $1.00 / g 1g 99% 20kg Career Henan Chemical Co
  • 	PF-06282999 pictures
  • PF-06282999
    1435467-37-0
  • US $1.00 / g
  • 99%
  • Career Henan Chemical Co

PF-06282999 Spectrum

PF-06282999 PF-06282999 (Free base) 2-(6-(5-chloro-2-methoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamide CS-2543 PF-06282999;PF 06282999;PF06282999 1(2H)-Pyrimidineacetamide, 6-(5-chloro-2-methoxyphenyl)-3,4-dihydro-4-oxo-2-thioxo- PF-06282999 >=98% (HPLC) PF06282999,Glutathione Peroxidase,PF 06282999,PF-06282999,Inhibitor,inhibit PF-06282999, 10 mM in DMSO PF-06282999 (PF06282999 1435467-37-0